If cost is the barrier KFF.org reports that more than 50 percent of adults say they have difficulty paying for GLP-1s thats a conversation worth having with your provider, not a problem to solve with a pill cutter
Understanding why medical oversight and regulated sourcing are important when exploring peptide-based wellness therapies
By Oct, Mounjaro (tirzepatide) had become the highest-selling drug by value, with sales reaching Rs 100 crore, according to Pharmarack, which tracks major Indian pharmaceuticals
[PubMed] [Google Scholar] Hemby SE, Trojanowski JQ, Ginsberg SD (2003) Neuron-specific age-related decreases in dopamine receptor subtype mRNAs
Zhou L, Qu H, Yang L, Shou L (2023) Effects of GLP1 receptor agonists on pregnancy rate and menstrual cyclicity in women with polycystic ovary syndrome: A meta-analysis and systematic review